晚发型下坡型听力损失的遗传因素及其对听觉康复的启示
研究对18例晚发型下坡型感音神经性听力损失患者行全外显子组测序,6例(33.3%)检出可能致病性变异,涉及MYH14、MYH9、USH2A、COL11A2和TMPRSS3基因,人工耳蜗及中耳植入效果满意,致病性变异阳性组与阴性组在发病年龄、家族史、纯音阈值和言语识别率上无统计学显著差异。
要点
- 晚发型下坡型听力损失患者中33.3%检出可能致病性变异。
- 检出变异涉及MYH14、MYH9、USH2A、COL11A2和TMPRSS3基因。
- 人工耳蜗及中耳植入在检出致病性变异的患者中效果满意。
核心结论
- 晚发型下坡型听力损失患者中检出可能致病性变异比例高达33.3%。
- 识别致病性变异有助于了解听力损失进展、预后及听觉康复方式,并提示可能伴随的综合征特征。
研究设计与样本
- 研究纳入来自三级转诊医院听力损失队列的18例无亲缘关系的晚发型下坡型感音神经性听力损失先证者,其中单纯型家系9个、复杂型家系9个。
- 下坡型听力损失定义为250 Hz和500 Hz平均低频阈值≤40 dB HL且1、2、4 kHz平均高频阈值>40 dB HL。
- 研究采用全外显子组测序和分离分析鉴定遗传病因,并评估患者的听觉康复效果。
主要发现
- 18例先证者中6例检出致病性变异,检出率为33.3%。
- 检出变异包括5个新变异和3个已知变异,位于MYH14、MYH9、USH2A、COL11A2和TMPRSS3基因。
- 检出致病性变异的患者接受人工耳蜗及中耳植入后效果满意。
- 致病性变异阳性组与阴性组在发病年龄、听力损失家族史、纯音阈值和言语识别率方面无统计学显著差异。
临床怎么用
- 对晚发型下坡型感音神经性听力损失患者可考虑进行基因检测以明确病因。
- 检出致病性变异有助于为听觉康复方式的选择和预后判断提供信息。
- 作者认为识别致病性变异可提示可能伴随的综合征特征。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Late-onset, down-sloping sensorineural hearing loss has many genetic and nongenetic etiologies, but the proportion of this commonly encountered type of hearing loss attributable to genetic causes is not well known. In this study, the authors performed genetic analysis using next-generation sequencing techniques in patients showing late-onset, down-sloping sensorineural hearing loss with preserved low-frequency hearing, and investigated the clinical implications of the variants identified. DESIGN: From a cohort of patients with hearing loss at a tertiary referral hospital, 18 unrelated probands with down-sloping sensorineural hearing loss of late onset were included in this study. Down-sloping hearing loss was defined as a mean low-frequency threshold at 250 Hz and 500 Hz less than or equal to 40 dB HL and a mean high-frequency threshold at 1, 2, and 4 kHz greater than 40 dB HL. The authors performed whole-exome sequencing and segregation analysis to identify the genetic causes and evaluated the outcomes of auditory rehabilitation in the patients. RESULTS: There were nine simplex and nine multiplex families included, in which the causative variants were found in six of 18 probands, demonstrating a detection rate of 33.3%. Various types of variants, including five novel and three known variants, were detected in the MYH14, MYH9, USH2A, COL11A2, and TMPRSS3 genes. The outcome of cochlear and middle ear implants in patients identified with pathogenic variants was satisfactory. There was no statistically significant difference between pathogenic variant-positive and pathogenic variant-negative groups in terms of onset age, family history of hearing loss, pure-tone threshold, or speech discrimination scores. CONCLUSIONS: The proportion of patients with late-onset, down-sloping hearing loss identified with potentially causative variants was unexpectedly high. Identification of the causative variants will offer insights on hearing loss progression and prognosis regarding various modes of auditory rehabilitation, as well as possible concomitant syndromic features.
引用
- Song MH, Jung J, Rim JH, et al. Genetic Inheritance of Late-Onset, Down-Sloping Hearing Loss and Its Implications for Auditory Rehabilitation. Ear Hear. 2020. PMID: 31045651. doi:10.1097/AUD.0000000000000734
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。